Shengnan Yu

1.4k total citations · 2 hit papers
25 papers, 942 citations indexed

About

Shengnan Yu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Shengnan Yu has authored 25 papers receiving a total of 942 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Immunology. Recurrent topics in Shengnan Yu's work include interferon and immune responses (2 papers), Advanced Image Fusion Techniques (2 papers) and HER2/EGFR in Cancer Research (2 papers). Shengnan Yu is often cited by papers focused on interferon and immune responses (2 papers), Advanced Image Fusion Techniques (2 papers) and HER2/EGFR in Cancer Research (2 papers). Shengnan Yu collaborates with scholars based in China, Hong Kong and United States. Shengnan Yu's co-authors include Kongming Wu, Qian Liu, Xudong Yao, Qian Chu, Xun Yuan, Shuang Qin, Weiheng Zhao, Xinwei Han, Anping Li and Qian Liu and has published in prestigious journals such as Scientific Reports, Molecular Cancer and Transplantation.

In The Last Decade

Shengnan Yu

20 papers receiving 921 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EGFR-TKIs resistance via EGFR-independent signaling pathways

2018 288 citations Qian Liu, Shengnan Yu et al. Molecular Cancer profile →
Advances on immunotherapy for osteosarcoma

2024 85 citations Shengnan Yu, Xudong Yao Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shengnan Yu China	10	503	376	243	177	156	25	942
Miriam Redrado Spain	20	518 1.0×	544 1.4×	177 0.7×	233 1.3×	270 1.7×	39	1.1k
Yongsheng Wang China	20	545 1.1×	310 0.8×	196 0.8×	282 1.6×	119 0.8×	54	927
Catalin Mihalcioiu Canada	14	422 0.8×	391 1.0×	156 0.6×	155 0.9×	283 1.8×	38	1000
Bruno A. Duso Italy	9	422 0.8×	354 0.9×	186 0.8×	189 1.1×	255 1.6×	21	879
Johanna Tuomela Finland	19	327 0.7×	537 1.4×	174 0.7×	188 1.1×	179 1.1×	49	984
Elizabeth Liniker Australia	10	566 1.1×	377 1.0×	202 0.8×	243 1.4×	79 0.5×	17	1.1k
Mónica Musteanu Spain	14	552 1.1×	415 1.1×	149 0.6×	121 0.7×	181 1.2×	32	972
Habib Sadeghirad Australia	7	509 1.0×	238 0.6×	146 0.6×	298 1.7×	82 0.5×	14	837

Countries citing papers authored by Shengnan Yu

Since Specialization

Citations

This map shows the geographic impact of Shengnan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengnan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengnan Yu more than expected).

Fields of papers citing papers by Shengnan Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengnan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengnan Yu. The network helps show where Shengnan Yu may publish in the future.

Co-authorship network of co-authors of Shengnan Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Shengnan Yu. A scholar is included among the top collaborators of Shengnan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengnan Yu. Shengnan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Hao, et al.. (2025). The Prognostic Value of the Systemic Immune-Inflammation Index in Glioblastoma Patients and the Establishment of a Nomogram. Current Medical Science. 45(3). 481–493.

Yu, Juan, Jian Mei, Mingxing Zhang, et al.. (2024). Inflammatory factor-mediated miR-155/SOCS1 signaling axis leads to Treg impairment in systemic lupus erythematosus. International Immunopharmacology. 141. 113013–113013. 7 indexed citations

Xu, Hao, et al.. (2024). Extended cycles of adjuvant temozolomide improves survival outcomes in glioblastoma: a retrospective analysis. Journal of Cancer Metastasis and Treatment. 1 indexed citations

Yu, Shengnan & Xudong Yao. (2024). Advances on immunotherapy for osteosarcoma. Molecular Cancer. 23(1). 192–192. 85 indexed citations breakdown →

Ren, Yongcheng, Lulu Cheng, Yuting Yang, et al.. (2024). Ideal cardiovascular health index and high-normal blood pressure in elderly people: evidence based on real-world data. Scientific Reports. 14(1). 10166–10166.

Gao, Qi, Shengnan Yu, Yuan Shi, et al.. (2024). Using empirical dynamic modeling to identify the impact of meteorological factors on hemorrhagic fever with renal syndrome in Weifang, Northeastern China, from 2011 to 2020. PLoS neglected tropical diseases. 18(6). e0012151–e0012151. 2 indexed citations

Yu, Shengnan, Xiaoyun Yang, Sha Ma, et al.. (2024). The diagnostic value and clinical relevance of high frequency ultrasound and shear wave elastography in systemic sclerosis: an observational monocentric study. Clinical Rheumatology. 43(12). 3759–3769.

Feng, Ruyi, et al.. (2023). MSISR-STF: Spatiotemporal Fusion via Multilevel Single-Image Super-Resolution. Remote Sensing. 15(24). 5675–5675. 7 indexed citations

Yu, Shengnan, et al.. (2023). Coincidence of Systemic Lupus Erythematosus and ANCA-Associated Vasculitis: A Case Report with Perforation of Nasal Septum and Palate. Journal of Inflammation Research. Volume 16. 5949–5957. 1 indexed citations

10.

Yang, Yan, Yunhan Ma, Shengnan Yu, et al.. (2022). TIPE2 knockout reduces myocardial cell damage by inhibiting IFN-γ-mediated ferroptosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(1). 166566–166566. 6 indexed citations

11.

Lao, Terence T., et al.. (2021). Impact of childbirth policy changes on obstetric workload over a 13-year period in a regional referral center in China – implications on service provision planning. BMC Pregnancy and Childbirth. 21(1). 610–610. 1 indexed citations

12.

Sun, Qian, et al.. (2021). Chronic maternal hepatitis B virus infection and pregnancy outcome- a single center study in Kunming, China. BMC Infectious Diseases. 21(1). 253–253. 17 indexed citations

13.

Yu, Shengnan, Shiqi Chen, Jia Jin, et al.. (2020). Relative Telomere Length in Peripheral Blood Cells and Hypertension Risk among Mine Workers: A Case‐Control Study in Chinese Coal Miners. BioMed Research International. 2020(1). 5681096–5681096. 5 indexed citations

14.

Yu, Shengnan, Li-Yi Zhang, Ke An, et al.. (2020). Live birth after cervical ectopic uterus transplantation in mice. American Journal of Transplantation. 20(8). 2226–2233. 5 indexed citations

15.

Yao, Xudong, Shengnan Yu, Xingzhi Jing, et al.. (2020). PTEN inhibitor VO-OHpic attenuates GC-associated endothelial progenitor cell dysfunction and osteonecrosis of the femoral head via activating Nrf2 signaling and inhibiting mitochondrial apoptosis pathway. Stem Cell Research & Therapy. 11(1). 140–140. 38 indexed citations

16.

Yu, Shengnan, Jing Zhang, Yongxiang Yan, et al.. (2019). A novel asymmetrical anti-HER2/CD3 bispecific antibody exhibits potent cytotoxicity for HER2-positive tumor cells. Journal of Experimental & Clinical Cancer Research. 38(1). 355–355. 61 indexed citations

17.

Liu, Qian, Shengnan Yu, Weiheng Zhao, et al.. (2018). EGFR-TKIs resistance via EGFR-independent signaling pathways. Molecular Cancer. 17(1). 53–53. 288 indexed citations breakdown →

18.

Yi, Ming, et al.. (2018). Progression and prognostic value of ECT2 in non-small-cell lung cancer and its correlation with PCNA. Cancer Management and Research. Volume 10. 4039–4050. 12 indexed citations

19.

Xu, Hanxiao, Shengnan Yu, Qian Liu, et al.. (2017). Recent advances of highly selective CDK4/6 inhibitors in breast cancer. Journal of Hematology & Oncology. 10(1). 97–97. 124 indexed citations

20.

Yu, Shengnan, Anping Li, Qian Liu, et al.. (2017). Chimeric antigen receptor T cells: a novel therapy for solid tumors. Journal of Hematology & Oncology. 10(1). 78–78. 234 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact